Please note that the following translation is a machine translation (Google translate).
The news pages are translated using machine translation (google translate), and so therefore may not be completely accurate. Please take this into consideration when reading. There may also be parts that cannot be translated by machine translation such as images, pdfs etc.
Please select your preferred language for google translated from the toolbar above.
Association of increasing gross tumor volume dose with tumor volume reduction and local control in fractionated stereotactic radiosurgery for unresected brain metastases.
<著者>
Naoyuki Kanayama, Toshiki Ikawa, Koji Takano, Hideyuki Arita, Masahiro Morimoto, Takero Hirata, Kazuhiko Ogawa, Teruki Teshima, Koji Konishi
<学会誌等>
Radiat Oncol 19(1) 95, 2024.
<タイトル>
Stereotactic Ablative Radiotherapy for Early-stage Lung Cancer in Patients With Left Ventricular Assist Device: A Case Series.
<著者>
Hayashi K, Ishikawa H, Fujiwara K, Nakai M, Ono H, Fumimoto Y, Tamaki N, Tatekawa S, Hirata T, Kimura T, Hirata H, Tamari K, Takeda Y, Shimizu S, Shintani Y, Ogawa K.
<学会誌等>
Anticancer Res.44(9):4113-4117.2024
<タイトル>
Prognostic analysis of radiation-induced liver damage following carbon-ion radiotherapy for hepatocellular carcinoma.
<著者>
Hayashi K, Suzuki O, Wakisaka Y, Ichise K, Uchida H, Anzai M, Hasegawa A, Seo Y, Shimizu S, Ishii T, Teshima T, Fujimoto J, Ogawa K.
<学会誌等>
Radiation Oncology 22;19(1):51.2024
【2023年度】
<タイトル>
“Validation of robust radiobiological optimization algorithms based on the mixed beam model for intensity-modulated carbon-ion therapy”
<著者>
M. Yagi, T. Tsubouchi, N. Hamatani, M. Takashina, T. Kanai
<学会誌等>
PLoS ONE 18(7): e0288545 (2023)
<タイトル>
Carbon-ion radiotherapy for oligometastatic liver disease: A national multicentric study by the Japan Carbon-Ion Radiation Oncology Study Group (J-CROS).
<著者>
Shiba S, Wakatsuki M, Toyama S, Terashima K, Uchida H, Katoh H, Shibuya K, Okazaki S, Miyasaka Y, Ohno T, Tsuji H.
<学会誌等>
Cancer Sci. 2023 Sep;114(9):3679-3686. doi:10.1111/cas.15871. Epub 2023 Jun 30. PMID:37391921; PMCID:PMC10475754.
<タイトル>
Linear accelerator-based stereotactic radiotherapy for brain metastases, including multiple and large lesions, carries a low incidence of acute toxicities: a retrospective analysis. Radiat Oncol.
<著者>
Ikawa T, Kanayama N, Arita H, Ohira S, Takano K, Hirata T, Morimoto M, Teshima T, Konishi K.
<学会誌等>
2023 May 10;18(1):80. doi:10.1186/s13014-023-02262-z. PMID:37165431; PMCID:PMC10173492.
<タイトル>
Japanese Society For Radiation Oncology Database Committee. A JROD survey: nationwide overview of radiotherapy data from 2015 to 2021.
<著者>
Ohba H, Nakada Y, Numasaki H, Umehara K, Ota J, Okuda Y, Teshima T, Ogawa K, Nakamura K
<学会誌等>
J Radiat Res. 2023 Nov 21;64(6):904-910. doi:10.1093/jrr/rrad067. PMID: 37738418;PMCID:PMC10665294.
<タイトル>
Clinical results of carbon-ion radiotherapy for stage I non-small cell lung cancer with concomitant interstitial lung disease: a Japanese national registry study (J-CROS-LUNG).
<著者>
Okano N, Suefuji H, Nakajima M, Tokumaru S, Kubo N, Yoshida D, Suzuki O, Ishikawa H, Satouchi M, Nakayama H, Shioyama Y.
<学会誌等>
J Radiat Res. 2023 Jun 16;64(Supplement_1):i2-i7. doi:10.1093/jrr/rrad008. PMID:37036751; PMCID:PMC10278880.
<タイトル>
Particle beam therapy versus photon radiotherapy for extrahepatic biliary cancer-systemic review and meta-analysis.
<著者>
Yamazaki H, Kimoto T, Teramukai S, Fujikawa K, Shibuya K, Suzuki M, Terashima K, Iizumi T, Wakatsuki M, Suzuki O, Fukumoto T, Ohtsuka M.
<学会誌等>
J Radiat Res. 2023 Jun 16;64(Supplement_1):i34-i40. doi:10.1093/jrr/rrad015. PMID: 37036780; PMCID:PMC10278884.
<タイトル>
Increased toxicities associated with dose escalation of stereotactic body radiation therapy in prostate cancer: results from a phase I/II study. Acta Oncol.
<著者>
Hirata T, Suzuki O, Otani K, Miyake A, Tamari K, Seo Y, Isohashi F, Kai N, Hatano K, Fujita K, Uemura M, Imamura R, Tamenaga S, Yoshino Y, Fumimoto Y, Yoshioka Y, Nonomura N, Ogawa K.
<学会誌等>
2023 May;62(5):488-494. doi:10.1080/0284186X.2023.2213443. Epub 2023 May 18. PMID:37203203.
<タイトル>
Innovative Combination Treatment to Expand the Indications of Particle Therapy:Spacer Placement Surgery Using Bio-Absorbable Polyglycolic Acid Spacer.
<著者>
Komatsu S, Wang T, Terashima K, Demizu Y, Anzai M, Suga M, Yamashita T, Suzuki O, Okimoto T, Sasaki R, Fukumoto T.
<学会誌等>
J Am Coll Surg. 2024 Jan 1;238(1):119-128. doi:10.1097/XCS.0000000000000873. Epub 2023 Sep 22. PMID: 37737669.
<タイトル>
Dose Rate Effect on Cell Survival in BNCT. Curr Issues Mol Biol.
<著者>
Hirose K, Sato M, Ichise K, Aoki M.
<学会誌等>
2023 Aug 23;45(9):6986-6994. doi: 10.3390/cimb45090441. PMID:37754225; PMCID:PMC10530115.
<タイトル>
Investigation of the efficacy of the change ratio of brain natriuretic peptide for predicting the cardiac effects of chemoradiotherapy on esophageal cancer. Oncol Lett.
<著者>
Hatayama Y, Kudo S, Ota R, Kuroki A, Tanaka M, Yotsuya C, Ichise K, Fujioka I, Sato M, Kawaguchi H, Aoki M.
<学会誌等>
2023 Aug 23;26(4):439. doi:10.3892/ol.2023.14026. PMID:37664653; PMCID:PMC10472025.
<タイトル>
Hepatobiliary Oncology Group (KHBO). Randomized phase III study of gemcitabine, cisplatin plus S-1 versus gemcitabine, cisplatin for advanced biliary tract cancer (KHBO1401- MITSUBA).
<著者>
Ioka T, Kanai M, Kobayashi S, Sakai D, Eguchi H, Baba H, Seo S, Taketomi A, Takayama T, Yamaue H, Takahashi M, Sho M, Kamei K, Fujimoto J, Toyoda M, Shimizu J, Goto T, Shindo Y, Yoshimura K, Hatano E, Nagano H; Kansai
Randomized phase III study of gemcitabine, cisplatin plus S-1 versus gemcitabine, cisplatin for advanced biliary tract cancer (KHBO1401-MITSUBA).
<著者>
Ioka, T, Kanai M, Kobayashi S, Sakai D, Eguchi H, Baba H, Seo S, Taketomi A, Takayama T, Yamaue H, Takahashi M,Sho M, Kamei K, Fujimoto J, Toyoda M, Shimizu J, Goto T, Shindo Y, Yoshimura K,Hatano E, Nagano H.
<学会誌等>
J Hepatobiliary pancreat Sci. 2023, (30): 102-110
【2021年度】
<タイトル>
Commissioning of carbon-ion radiotherapy for moving targets at the Osaka Heavy-Ion Therapy Center
<著者>
N. Hamatani, T. Tsubouchi, M. Takashina, M. Yagi, T. Kanai
<学会誌等>
Med. Phys. 2021, 1-12
<タイトル>
“Carbon ion radiotherapy using fiducial markers for prostate cancer in Osaka HIMAK: Treatment planning”
<著者>
T. Tsubouchi, N. Hamatani, M. Takashina, Y. Wakisaka, A. Ogawa, M. Yagi, A. Terasawa, K. Shimazaki, M. Chatani, J. Mizoe, T. Kanai
<学会誌等>
J Appl Clin Med Phys 2021; 22:242–251.
<タイトル>
Physical and biological beam modeling for carbon beam scanning at Osaka Heavy Ion Therapy Center
<著者>
S. Fujitaka, Y. Fujii, H. Nihongi, S. Nakayama, M. Takashina, N. Hamatani, T. Tsubouchi, M. Yagi, K. Minami, K. Ogawa, J. Mizoe, T. Kanai
<学会誌等>
J Appl Clin Med Phys 2021;22:7:77–92
<タイトル>
“Stereotactic Ablative Radiotherapy Using CyberKnife for Stage I Non-small-cell Lung Cancer: A Retrospective Analysis”